Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: J Steroid Biochem Mol Biol. 2017 Jul 29;177:149–154. doi: 10.1016/j.jsbmb.2017.07.005

Figure 2.

Figure 2

A. Inhibition of JNK activity by SP600125 reduces protein levels of FOXO3a and BIM in cells with AraC-induced cell damage treated with D2/CA. The levels of cleaved Caspases 9 and 3 are also reduced in these cells. B. The reduction of the enhancement of the cell death by D2/CA by inhibition of JNK phosphorylation parallels the molecular changes shown in panel A. *= p < 0.05, when compared with AraC treated group. # = p < 0.05, when compared with corresponding control group. N=3